Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2016

Lingzhi Wang's Biography



Lingzhi Wang, Senior Research Scientist, Ctr. for Translational Medicine, Adjunct Professor, National University of Singapore

Lingzhi Wang is a Senior Research Scientist of Cancer Science Institute of Singapore. He is also an adjunct Assistant Professor of Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore. He received his Ph.D. in Pharmacology from National University of Singapore. His research interest focuses on Cancer Therapeutics, Pharmacogenetics, Pharmacokinetics and Cancer Biomarker Discovery. Dr. Wang, one of pioneers in tumour-derived exosomes research in Singapore, was invited as a speaker to share his work on exosome cancer biomarker discovery in the Inaugural Socrates Scientific Meeting 2013. He possesses extensive experience in small molecules and protein quantification by mass spectrometry. Dr. Wang is the Principal Investigator of Validation of Candidate Biomarkers in Plasma for Diagnosis and Prognosis of Lung Cancer funded by National Medical Research Council, Singapore.

Lingzhi Wang Image

Protein Profiling of Tumour-derived Exosomes for Plasma Biomarker Discovery in Non-Small Cell Lung Cancer

Friday, 30 September 2016 at 14:30

Add to Calendar ▼2016-09-30 14:30:002016-09-30 15:30:00Europe/LondonProtein Profiling of Tumour-derived Exosomes for Plasma Biomarker Discovery in Non-Small Cell Lung CancerLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Lung cancers are often diagnosed at advanced stages with concomitant poor prognosis, making it the leading cause of cancer mortality worldwide. Although low-dose CT have shown to be useful in detecting small abnormalities in the lung and associated with a 20% reduction in lung cancer-specific mortality, they have also been found to have high false positive rate of detection (96.4%) in a recent U.S.A. National screening trial. It is thus important to identify novel minimally-invasive lung cancer biomarkers. Circulating exosomes are important resources for cancer biomarker discovery because exosomes can reflect the cell’s RNA and protein contents from which they are secreted.


Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2016Liquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com